Medical Journals

Mta1, a Transcriptional Activator of Breast Cancer Amplified Sequence 3.

Authors:
  • Gururaj Anupama E
  • Singh Rajesh R
  • Rayala Suresh K
  • Holm Caroline
  • den Hollander Petra
  • Zhang Hao
  • Balasenthil Seetharaman
  • Talukder Amjad H
  • Landberg Goran
  • Kumar Rakesh

From: Department of Molecular and Cellular Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

Proceedings of the National Academy of Sciences of the United States of America

  • Publish Date: Apr 2006
  • ISSN: 0027-8424
  • Volume: 103
  • Issue: 17
  • Pages: 6670-5
  • Medium: Print
  • Language: English
  • Citation (JAMA): Gururaj Anupama E, Singh Rajesh R, Rayala Suresh K, et al. Mta1, a Transcriptional Activator of Breast Cancer Amplified Sequence 3.. Proc. Natl. Acad. Sci. U.S.A. Apr 2006;103:6670-5

Abstract

Here we define a function of metastasis-associated protein 1 (MTA1), a presumed corepressor of estrogen receptor alpha (ERalpha), as a transcriptional activator of Breast Cancer Amplified Sequence 3 (BCAS3), a gene amplified and overexpressed in breast cancers. We identified BCAS3 as a MTA1 chromatin target in a functional genomic screen. MTA1 stimulation of BCAS3 transcription required ERalpha and involved a functional ERE half-site in BCAS3. Furthermore, we discovered that MTA1 is acetylated on lysine 626, and that this acetylation is necessary for a productive transcriptional recruitment of RNA polymerase II complex to the BCAS3 enhancer sequence. BCAS3 expression was elevated in mammary tumors from MTA1 transgenic mice and 60% of the human breast tumors, and correlated with the coexpression of MTA1 as well as with tumor grade and proliferation of primary breast tumor samples. These findings reveal a previously unrecognized function of MTA1 in stimulating BCAS3 expression and suggest an important role for MTA1-BCAS3 pathway in promoting cancerous phenotypes in breast tumor cells.

Mesh Headings (Keywords): Acetylation, Amino Acid Sequence, Base Sequence, Binding Sites, Breast Neoplasms, Cell Line, Tumor, DNA, Neoplasm, Enhancer Elements (Genetics), Estradiol, Estrogen Receptor alpha, Female, Gene Expression Regulation, Neoplastic, Histone Deacetylases, Humans, Molecular Sequence Data, Neoplasm Proteins, Repressor Proteins, Trans-Activators


Check for Full Text / PubMed Unique Identifier (PMID): 16617102


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.